An Efficacy & Safety Study of Ha44 Gel Administered Topically for

Updated 06/21/2024

Status Completed

Clinical Trial Summary

Phase 2 study to assess the safety and effectiveness of a product to treat children and adults with head lice

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01336647
Study type	Interventional
Source	Dr. Reddy's Laboratories Limited
Contact
Status	Completed
Phase	Phase 2
Start date	April 2011
Completion date	March 2012

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01660321` - Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation	Phase 4
	Completed	`NCT00752973` - Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice	Phase 2/Phase 3
	Completed	`NCT00545753` - Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice	Phase 3
	Completed	`NCT00381082` - A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.	Phase 2/Phase 3
	Terminated	`NCT02499549` - Two Treatment Regimens of Cocamide DEA Lotion for Head Lice	Phase 2/Phase 3
	Completed	`NCT05643820` - Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis	Phase 1
	Completed	`NCT00731718` - Control of Head Lice Infestations in Children and Adults	N/A
	Not yet recruiting	`NCT01966965` - Efficacy and Safety Study for PIOLIN® Shampoo	Phase 3
	Completed	`NCT00927407` - Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice	Phase 1
	Completed	`NCT01518699` - Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers	Phase 1
	Completed	`NCT00207753` - Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections	N/A
	Completed	`NCT00963508` - Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice	Phase 3
	Completed	`NCT00927472` - Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice	Phase 3